Solara Active Pharma Sciences Ltd. SOLARA
NSE · India · Health Technology
INR 714.85-10.55 (-1.45%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Solara Active Pharma Sciences Ltd (BOM:541540) reports a 20% revenue increase and significant debt reduction, while navigating profitability issues in its Ibuprofen segment.
Solara Active Pharma Sciences Ltd (BOM:541540) reports significant growth in revenue and EBITDA, while addressing challenges in the Ibuprofen segment.
Despite a challenging quarter marked by operational disruptions, Solara Active Pharma Sciences Ltd (BOM:541540) focuses on debt reduction and maintaining a strong presence in regulated markets.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.